{"id":"https://openalex.org/W4400740010","doi":"https://doi.org/10.1186/s12886-024-03564-w","title":"Recombinant human nerve growth factor (cenegermin) for moderate-to-severe dry eye: phase II, randomized, vehicle-controlled, dose-ranging trial","display_name":"Recombinant human nerve growth factor (cenegermin) for moderate-to-severe dry eye: phase II, randomized, vehicle-controlled, dose-ranging trial","publication_year":2024,"publication_date":"2024-07-17","ids":{"openalex":"https://openalex.org/W4400740010","doi":"https://doi.org/10.1186/s12886-024-03564-w","pmid":"https://pubmed.ncbi.nlm.nih.gov/39020305","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11253442"},"language":"en","primary_location":{"id":"doi:10.1186/s12886-024-03564-w","doi":"https://doi.org/10.1186/s12886-024-03564-w","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-024-03564-w","pdf_url":"https://bmcophthalmol.biomedcentral.com/counter/pdf/10.1186/s12886-024-03564-w","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcophthalmol.biomedcentral.com/counter/pdf/10.1186/s12886-024-03564-w","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010870123","display_name":"David Wirta","orcid":"https://orcid.org/0000-0003-4725-5361","observed_orcids":["https://orcid.org/0000-0003-4725-5361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Wirta","raw_affiliation_strings":["Eye Research Foundation, 520 Superior Avenue, Suite 235, Newport Beach, CA, 92663, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Research Foundation, 520 Superior Avenue, Suite 235, Newport Beach, CA, 92663, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005626128","display_name":"William Lipsky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Lipsky","raw_affiliation_strings":["Advanced Laser Vision & Surgical Institute and Intouch Clinical Research Center, 11550 Fuqua Street, Suite 250, Houston, TX, 77034, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Laser Vision & Surgical Institute and Intouch Clinical Research Center, 11550 Fuqua Street, Suite 250, Houston, TX, 77034, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029544057","display_name":"Melissa Morrison Toyos","orcid":"https://orcid.org/0000-0003-4529-9643","observed_orcids":["https://orcid.org/0000-0003-4529-9643"]},"institutions":[{"id":"https://openalex.org/I4405267023","display_name":"Toyos Clinic","ror":"https://ror.org/00w7v7a37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405267023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Toyos","raw_affiliation_strings":["Toyos Clinic, 2204 Crestmoor Road, Nashville, TN, 37215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toyos Clinic, 2204 Crestmoor Road, Nashville, TN, 37215, USA","institution_ids":["https://openalex.org/I4405267023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024161557","display_name":"Joseph Martel","orcid":"https://orcid.org/0000-0001-8888-9286","observed_orcids":["https://orcid.org/0000-0001-8888-9286"]},"institutions":[{"id":"https://openalex.org/I4210114026","display_name":"Martel","ror":"https://ror.org/01gk6p474","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210114026"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Joseph Martel","raw_affiliation_strings":["Martel Eye Medical Group, 11216 Trinity River Drive, Rancho Cordova, CA, 95670, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Martel Eye Medical Group, 11216 Trinity River Drive, Rancho Cordova, CA, 95670, USA","institution_ids":["https://openalex.org/I4210114026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080735639","display_name":"John D. Goosey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148918","display_name":"Houston Eye Associates","ror":"https://ror.org/03yqk8w89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148918"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Goosey","raw_affiliation_strings":["Houston Eye Associates, 2855 Gramercy Street, Houston, TX, 77025, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Houston Eye Associates, 2855 Gramercy Street, Houston, TX, 77025, USA","institution_ids":["https://openalex.org/I4210148918"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031214545","display_name":"Anthony Verachtert","orcid":"https://orcid.org/0009-0007-6161-7257","observed_orcids":["https://orcid.org/0009-0007-6161-7257"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Verachtert","raw_affiliation_strings":["Moyes Eye Center, 5151 NW 88 Street, Kansas City, MO, 64154, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moyes Eye Center, 5151 NW 88 Street, Kansas City, MO, 64154, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059771044","display_name":"Sh\u00e9rif M. El-Harazi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sherif El-Harazi","raw_affiliation_strings":["Global Research Management, 1510 S Central Avenue, Glendale, CA, 91204, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Research Management, 1510 S Central Avenue, Glendale, CA, 91204, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088888181","display_name":"Paul M Karpecki","orcid":"https://orcid.org/0000-0003-1390-2532","observed_orcids":["https://orcid.org/0000-0003-1390-2532"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Karpecki","raw_affiliation_strings":["Kentucky Eye Institute, 601 Perimeter Drive, Suite 100, Lexington, KY, 40517, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kentucky Eye Institute, 601 Perimeter Drive, Suite 100, Lexington, KY, 40517, USA","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082541243","display_name":"Marcello Allegretti","orcid":"https://orcid.org/0000-0002-0617-0233","observed_orcids":["https://orcid.org/0000-0002-0617-0233"]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marcello Allegretti","raw_affiliation_strings":["Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052834144","display_name":"Giovanni Goisis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Goisis","raw_affiliation_strings":["Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014777319","display_name":"Georgea Pasedis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Georgea Pasedis","raw_affiliation_strings":["Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013431023","display_name":"Flavio Mantelli","orcid":"https://orcid.org/0000-0003-3459-4866","observed_orcids":["https://orcid.org/0000-0003-3459-4866"]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Flavio Mantelli","raw_affiliation_strings":["Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy. flavio.mantelli@dompe.com","Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy. flavio.mantelli@dompe.com","institution_ids":["https://openalex.org/I4210140932"]},{"raw_affiliation_string":"Domp\u00e9 farmaceutici S.p.A, Via Santa Lucia 6, Milan, 20122, Italy","institution_ids":["https://openalex.org/I4210140932"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5013431023"],"corresponding_institution_ids":["https://openalex.org/I4210140932"],"apc_list":{"value":2890,"currency":"USD","value_usd":2890},"apc_paid":{"value":2890,"currency":"USD","value_usd":2890},"fwci":5.9163,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.96859755,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"24","issue":"1","first_page":"290","last_page":"290"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cenegermin","display_name":"cenegermin","score":0.8700000047683716},{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.7689999938011169},{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.9010000228881836},{"id":"https://openalex.org/keywords/sjogren-s-syndrome","display_name":"Sj\u00f6gren's syndrome","score":0.8429999947547913},{"id":"https://openalex.org/keywords/schirmer-i-test","display_name":"Schirmer I test","score":0.800000011920929},{"id":"https://openalex.org/keywords/dose-ranging-study","display_name":"dose-ranging","score":0.5519999861717224},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.675000011920929},{"id":"https://openalex.org/keywords/neurotrophic-keratopathy","display_name":"neurotrophic keratopathy","score":0.7129999995231628},{"id":"https://openalex.org/keywords/dry-eye-symptoms","display_name":"dry eye symptoms","score":0.49300000071525574},{"id":"https://openalex.org/keywords/corneal-wound-healing","display_name":"corneal wound healing","score":0.5429999828338623},{"id":"https://openalex.org/keywords/ocular-surface-disease","display_name":"ocular surface disease","score":0.5989999771118164},{"id":"https://openalex.org/keywords/treatment-response-rate","display_name":"treatment response rate","score":0.32899999618530273},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9441996812820435},{"id":"https://openalex.org/C2776312127","wikidata":"https://www.wikidata.org/wiki/Q5299247","display_name":"Dose-ranging study","level":5,"score":0.624015212059021},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5535587668418884},{"id":"https://openalex.org/C2778423431","wikidata":"https://www.wikidata.org/wiki/Q417782","display_name":"Nerve growth factor","level":3,"score":0.5079541802406311},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4381702244281769},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.4143083691596985},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3517545461654663},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22878149151802063},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.16794824600219727},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.07498186826705933},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07468563318252563},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013666","descriptor_name":"Tears","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020932","descriptor_name":"Nerve Growth Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020932","descriptor_name":"Nerve Growth Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12886-024-03564-w","doi":"https://doi.org/10.1186/s12886-024-03564-w","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-024-03564-w","pdf_url":"https://bmcophthalmol.biomedcentral.com/counter/pdf/10.1186/s12886-024-03564-w","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11253442","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11253442","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11253442/pdf/12886_2024_Article_3564.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmol","raw_type":"Text"},{"id":"pmid:39020305","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39020305","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC ophthalmology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:1872344747c54643b26f84ebef66d9a6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1872344747c54643b26f84ebef66d9a6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Ophthalmology, Vol 24, Iss 1, Pp 1-13 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12886-024-03564-w","doi":"https://doi.org/10.1186/s12886-024-03564-w","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-024-03564-w","pdf_url":"https://bmcophthalmol.biomedcentral.com/counter/pdf/10.1186/s12886-024-03564-w","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400740010.pdf","grobid_xml":"https://content.openalex.org/works/W4400740010.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1596048577","https://openalex.org/W2003269720","https://openalex.org/W2012617770","https://openalex.org/W2022388170","https://openalex.org/W2048638072","https://openalex.org/W2048729493","https://openalex.org/W2052751137","https://openalex.org/W2054186928","https://openalex.org/W2057517520","https://openalex.org/W2079846656","https://openalex.org/W2083559535","https://openalex.org/W2088344821","https://openalex.org/W2088569154","https://openalex.org/W2095812936","https://openalex.org/W2108696783","https://openalex.org/W2147840299","https://openalex.org/W2175015138","https://openalex.org/W2236250692","https://openalex.org/W2724132216","https://openalex.org/W2737725878","https://openalex.org/W2737787547","https://openalex.org/W2749853594","https://openalex.org/W2889512770","https://openalex.org/W2890648071","https://openalex.org/W2933338902","https://openalex.org/W2933596385","https://openalex.org/W2970312470","https://openalex.org/W3000127325","https://openalex.org/W3023680900","https://openalex.org/W3106908696","https://openalex.org/W3120498583","https://openalex.org/W3200309023","https://openalex.org/W4212942249","https://openalex.org/W4213205662","https://openalex.org/W4214602460","https://openalex.org/W4231319766","https://openalex.org/W4294481990","https://openalex.org/W4294489724","https://openalex.org/W4388106878"],"related_works":["https://openalex.org/W6977490689","https://openalex.org/W6920997758","https://openalex.org/W6920953958","https://openalex.org/W6958625792","https://openalex.org/W6902196475","https://openalex.org/W2979174096","https://openalex.org/W2933338902","https://openalex.org/W4322495836","https://openalex.org/W2951842778","https://openalex.org/W3039318817"],"abstract_inverted_index":{"BACKGROUND:":[0],"Dry":[1,161],"eye":[2,352],"disease":[3],"(DED)":[4],"includes":[5],"neurosensory":[6],"abnormalities":[7],"as":[8],"part":[9],"of":[10,48,57,94,144,169,299,350],"its":[11,342],"multifactorial":[12],"etiology.":[13],"Nerve":[14],"growth":[15,31],"factor":[16],"is":[17,33],"important":[18],"for":[19,116,121],"maintaining":[20],"corneal":[21,39],"nerve":[22,30],"integrity":[23],"and":[24,55,62,109,155,214,245,309,335],"wound":[25],"healing.":[26],"Cenegermin":[27,331],"(recombinant":[28],"human":[29],"factor)":[32],"a":[34,71],"topical":[35],"biologic":[36],"that":[37],"promotes":[38],"healing":[40],"in":[41,59,81,130,157,189,198,273,287,325,347,361],"patients":[42,82,238,326,362],"with":[43,83,242,264,319,327,363],"neurotrophic":[44],"keratitis.":[45],"The":[46,125],"purpose":[47],"this":[49,337],"study":[50,338],"was":[51,70,128,177,311,332,353],"to":[52,136,167,179,224,232,240,296],"evaluate":[53,180],"efficacy":[54],"safety":[56],"cenegermin":[58,95,102,200,243,278,360],"moderate-to-severe":[60,84],"DED":[61,88,364],"identify":[63],"an":[64],"optimal":[65],"dosing":[66],"strategy.":[67],"METHODS:":[68],"This":[69],"phase":[72],"II,":[73],"multicenter,":[74],"randomized,":[75],"double-masked,":[76],"vehicle-controlled,":[77],"dose-ranging":[78],"clinical":[79],"trial":[80],"DED,":[85],"including":[86],"Sj\u00f6gren's":[87,328],"(NCT03982368).":[89],"Patients":[90],"received":[91],"1":[92],"drop":[93],"3":[96],"times":[97,104],"daily":[98,105],"(t.i.d.;":[99],"20":[100,107],"mcg/mL),":[101],"2":[103],"(b.i.d.;":[106],"mcg/mL)":[108],"vehicle":[110,114,203,206,248],"once":[111],"daily,":[112],"or":[113],"t.i.d.":[115,244,279],"4":[117],"weeks.":[118,124],"Follow-up":[119],"continued":[120],"12":[122],"additional":[123],"primary":[126,343],"endpoint":[127],"change":[129,156],"Schirmer":[131,190],"I":[132,147,191],"score":[133],"from":[134,165],"baseline":[135,166],"week":[137,185],"4.":[138],"Other":[139],"key":[140],"endpoints":[141],"included":[142],"rate":[143],"responders":[145],"(Schirmer":[146],"test":[148,173],">":[149],"10":[150],"mm/5":[151],"min)":[152],"after":[153],"treatment":[154,241],"Symptoms":[158],"Assessment":[159],"iN":[160],"Eye":[162,305],"(SANDE)":[163],"scores":[164,192,289],"end":[168,298],"follow-up.":[170,356],"A":[171],"1-sided":[172],"(\u03b1":[174],"=":[175,227,235,253,259],"0.025)":[176,271,285],"used":[178],"statistical":[181,265],"significance.":[182],"RESULTS:":[183],"At":[184],"4,":[186],"mean":[187],"changes":[188],"were":[193,293,323],"not":[194,340],"statistically":[195,281],"significantly":[196],"different":[197],"either":[199],"group":[201],"versus":[202,247,290],"(cenegermin":[204],"vs":[205,218,261],"[treatment":[207],"difference;":[208],"95%":[209],"CI]:":[210],"t.i.d.,":[211],"2.60":[212],"mm":[213,217,220],"b.i.d.,":[215],"3.99":[216],"1.68":[219],"[t.i.d.:":[221],"0.93;":[222],"-1.47":[223],"3.32,":[225],"P":[226,234,252,258,269],"0.078;":[228],"b.i.d.:":[229,255],"2.31;":[230],"-0.08":[231],"4.70,":[233],"0.066]).":[236],"More":[237],"responded":[239],"b.i.d.":[246,275],"(t.i.d.:":[249],"25.9%":[250],"[21/81,":[251],"0.028];":[254],"29.3%":[256],"[24/82,":[257],"0.007]":[260],"11.9%":[262],"[10/84]),":[263],"significance":[266],"(set":[267],"at":[268],"<":[270,284],"observed":[272,315,324,354],"the":[274,297,312],"group.":[276],"Only":[277],"yielded":[280],"significant":[282,345],"(P":[283,301],"reductions":[286],"SANDE":[288],"vehicle,":[291],"which":[292],"sustained":[294],"up":[295],"follow-up":[300],"value":[302],"range,":[303],"0.002-0.008).":[304],"pain,":[306],"primarily":[307],"mild":[308],"transient,":[310],"most":[313],"frequently":[314],"treatment-emergent":[316],"adverse":[317],"event":[318],"cenegermin.":[320],"Similar":[321],"results":[322],"DED.":[329],"CONCLUSIONS:":[330],"well":[333],"tolerated":[334],"although":[336],"did":[339],"meet":[341],"endpoint,":[344],"improvement":[346],"patient-reported":[348],"symptoms":[349],"dry":[351],"through":[355],"Larger":[357],"studies":[358],"evaluating":[359],"are":[365],"warranted.":[366],"TRIAL":[367],"REGISTRATION:":[368],"NCT03982368;":[369],"registered":[370],"May":[371],"23,":[372],"2019.":[373]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":9}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-07-18T00:00:00"}